BAKX Therapeutics

Boston, United States

BAKX Therapeutics is a provider of cancer treatment.

$25.0M raised

Nov 2021

Series A

Biotechnology Health Care Medical Oncology Therapeutics

Top Investors

Sherpa Healthcare Partners Ipsen AB Magnitude Ventures Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BAKX Therapeutics

How much funding has BAKX Therapeutics raised?

BAKX Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are BAKX Therapeutics's investors?

BAKX Therapeutics's investors include Sherpa Healthcare Partners, Ipsen, AB Magnitude Ventures Group.

Where is BAKX Therapeutics headquartered?

BAKX Therapeutics is headquartered in Boston, United States.

What does BAKX Therapeutics do?

BAKX Therapeutics is a provider of cancer treatment.

What stage is BAKX Therapeutics at?

BAKX Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 18, 2021.

MLA

"BAKX Therapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/bakx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). BAKX Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bakx-therapeutics

Wikipedia (cite web)

{{cite web |title=BAKX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bakx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 18, 2021.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K